13sn
From Proteopedia
(Difference between revisions)
m (Protected "13sn" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==PanDDA analysis group deposition -- IDOL RING domain in complex with Z2757439080== | |
| - | + | <StructureSection load='13sn' size='340' side='right'caption='[[13sn]], [[Resolution|resolution]] 1.44Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[13sn]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=13SN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=13SN FirstGlance]. <br> | |
| - | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.44Å</td></tr> | |
| - | [[Category: | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=Q7L:(3P)-3-(2H-1,3-benzodioxol-5-yl)-1H-pyrazole'>Q7L</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> |
| - | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=13sn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=13sn OCA], [https://pdbe.org/13sn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=13sn RCSB], [https://www.ebi.ac.uk/pdbsum/13sn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=13sn ProSAT]</span></td></tr> |
| - | [[Category: Bradshaw | + | </table> |
| - | [[Category: Murphy | + | == Function == |
| + | [https://www.uniprot.org/uniprot/MYLIP_HUMAN MYLIP_HUMAN] E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of myosin regulatory light chain (MRLC), LDLR, VLDLR and LRP8. Activity depends on E2 enzymes of the UBE2D family. Proteasomal degradation of MRLC leads to inhibit neurite outgrowth in presence of NGF by counteracting the stabilization of MRLC by saposin-like protein (CNPY2/MSAP) and reducing CNPY2-stimulated neurite outgrowth. Acts as a sterol-dependent inhibitor of cellular cholesterol uptake by mediating ubiquitination and subsequent degradation of LDLR.<ref>PMID:10593918</ref> <ref>PMID:14550572</ref> <ref>PMID:12826659</ref> <ref>PMID:19520913</ref> <ref>PMID:20427281</ref> <ref>PMID:22109552</ref> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Bradshaw WJ]] | ||
| + | [[Category: Guenther F]] | ||
| + | [[Category: Murphy EJ]] | ||
Current revision
PanDDA analysis group deposition -- IDOL RING domain in complex with Z2757439080
| |||||||||||
